The FDA is phasing out animal testing and moving to more human-relevant methods. This was announced as one of Marty Makary’s ...

A recent survey found that 82% of pharmaceutical industry professionals believe that digital transformation will either significantly or moderately shorten the drug development timeline.

In the face of such pressure, pharmaceutical companies are eager to reduce the cost of drug development so that consumer prices can be lowered without sacrificing profit margin. Fortunately ...

The president said he would build on the Medicare drug-price negotiation program begun under Joe Biden, but supports a change ...

The average cost for a Big Pharma to develop ... risk than incremental improvements on launched drugs and are more time consuming both in development and through regulatory approval, the rewards ...

This latest estimate from the Tufts Center for Drug Development of the cost of developing a new chemical entity to the point of submission for regulatory approval has already been widely debated.

President Donald Trump has signed an executive order looking to modify the Inflation Reduction Act’s (IRA's) drug price ...

The Trump administration aims to change the Medicare Drug Price Negotiation Program in a way that would delay when certain ...

The pharmaceutical industry has long been reliant on rigorous research and development processes ... reducing the time and cost once associated with bringing new drugs to market.

In a landmark shift, the US Food and Drug Administration (FDA) has announced a transformative initiative to advance public ...